Tacrolimus for the treatment of fistulas in patients with crohn’s disease: a randomized, placebo-controlled trial
- 1 August 2003
- journal article
- clinical trial
- Published by Elsevier BV in Gastroenterology
- Vol. 125 (2), 380-388
- https://doi.org/10.1016/s0016-5085(03)00877-1
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- MRI imaging of the effects of infliximab in perianal fistulizing Crohn's diseaseGastroenterology, 2001
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseThe New England Journal of Medicine, 1999
- Relationship of tacrolimus (FK506) whole blood concentrations and efficacy and safety after HLA-identical sibling bone marrow transplantationTransplantation and Cellular Therapy, 1998
- TacrolimusDrugs, 1997
- Usual Therapy Improves Perianal Crohn??s Disease as Measured by a New Disease Activity IndexJournal of Clinical Gastroenterology, 1995
- Efficacy of cyclosporine in treatment of fistula of crohn's diseaseDigestive Diseases and Sciences, 1994
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin ANature, 1991
- Favorable effect of 6-Mercaptopurine on fistulae of Crohn's diseaseDigestive Diseases and Sciences, 1985
- Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease.Gut, 1980